Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.316
-0.034 (-2.50%)
Nov 5, 2024, 1:03 PM EST - Market open
Kairos Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.02 | 0.09 | 0.44 | 0.07 |
Cash & Short-Term Investments | 0.02 | 0.09 | 0.44 | 0.07 |
Cash Growth | -90.95% | -78.72% | 498.63% | - |
Prepaid Expenses | 0.02 | 0.01 | - | - |
Total Current Assets | 0.04 | 0.1 | 0.44 | 0.07 |
Other Intangible Assets | 0.3 | 0.38 | 0.54 | 0.7 |
Long-Term Deferred Charges | 0.69 | 0.48 | 0.06 | - |
Accounts Payable | 2.9 | 2.4 | 1.63 | 1.55 |
Short-Term Debt | 0.11 | 0 | 0 | 0.39 |
Total Current Liabilities | 3.01 | 2.41 | 1.63 | 1.94 |
Long-Term Debt | 0.68 | 0.64 | 0.58 | - |
Common Stock | 0.01 | 0.01 | 0.01 | 0.1 |
Additional Paid-In Capital | 4.12 | 4.12 | 3.21 | 2.08 |
Retained Earnings | -6.79 | -6.21 | -4.4 | -3.35 |
Total Liabilities & Equity | 1.03 | 0.97 | 1.04 | 0.78 |
Total Debt | 0.78 | 0.64 | 0.59 | 0.39 |
Net Cash (Debt) | -0.76 | -0.55 | -0.15 | -0.32 |
Net Cash Per Share | -0.07 | -0.05 | -0.01 | -0.04 |
Filing Date Shares Outstanding | 10.56 | 10.56 | 10.33 | 9.15 |
Total Common Shares Outstanding | 10.56 | 10.56 | 10.33 | 9.15 |
Working Capital | -2.97 | -2.3 | -1.2 | -1.87 |
Book Value Per Share | -0.25 | -0.20 | -0.11 | -0.13 |
Tangible Book Value | -2.96 | -2.46 | -1.72 | -1.87 |
Tangible Book Value Per Share | -0.28 | -0.23 | -0.17 | -0.20 |
Source: S&P Capital IQ. Standard template.
Financial Sources.